Scientists of the DPZ in collaboration with TwistDx have developed a portable laboratory for the diagnosis of the ebola-virus.
RPA IN THE FIELD: Screening clinical samples from cattle at quarantine stations in Hurghada & Safaga
Recombinase Polymerase Amplification (RPA) was recently used to screen clinical samples from cattle at quarantine stations in Hurghada and Safaga to detect cattle shedding FMDV. Overall, 96 swabs were tested by the FMDV RPA assay. Fortunately all samples were negative. Photo's courtesy of the Departments of Virology at Goettingen and Cairo Universities.
Cambridge, UK, 29TH January, 2009 – TwistDx, a leading DNA diagnostics company, announced today that the company has been selected as a winner in an NHS competition to find new ways to help combat healthcare associated infections (HCAIs).
TwistDx, a developer of point-of-use nucleic acid diagnostics, announced today the launch of its TwistAmp™ product range, the world’s first DNA amplification products based on Recombinase Polymerase Amplification (RPA). Concurrently, TwistDx also launched the Twista™ portable, real-time fluorometer, an easy-to-use RPA reader. RPA is a proprietary technique, employing recombinase enzymes, used to amplify nucleic acids in any biological sample, with high analytical sensitivity and specificity.